TY  - JOUR
AU  - Marcé, Sílvia
AU  - Escribano Serrat, Silvia
AU  - Anguita Mandly, Eduardo Luis
AU  - Zamora, Lurdes
PY  - 2024
DO  - 10.3390/jcm13030779
SN  - 2077-0383
UR  - https://hdl.handle.net/20.500.14352/105332
T2  - Journal of clinical medicine
AB  - e13a2 and e14a2 are the most frequent transcript types of the BCR::ABL1 fusion gene in chronic myeloid leukemia (CML). The current goal with tyrosine kinase inhibitors (TKI) is to achieve sustained deep molecular response (DMR) in order to discontinue...
LA  - eng
M2  - 779
PB  - MDPI
KW  - Hematología
KW  - Leucemia mieloide crónica
KW  - Biología Molecular
TI  - e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response
TY  - journal article
VL  - 13
ER  -